BioCentury
ARTICLE | Company News

HistoRx, Metamark Genetics deal

January 3, 2011 8:00 AM UTC

Metamark received worldwide rights to HistoRx's AQUA fluorescent immunohistochemistry technology to commercialize Metamark's MetamarkDx Prognostic Assays. The assays identify patient tumor profiles th...